VG Life Sciences Inc. (VGLS)

[CE_of_red]

WhisperfromWallStreet VRAL Alert
Posted on 18 July 2010 by admin
Hello All, I hope everyone enjoyed there weekend and is ready for a big week of trading. Today's alert is a bio-tech company and we all know how explosive they can be. Remember last year when VERMILLION INC which traded on the pink sheets went from .05 to $28.45?? That was a 56,800% price gain!! Now Im not saying that is going to happen here but it does show you that when these little medical companies come out with good news the market can go crazy. Let's get to the alert. My new alert is Viral Genetics Inc., VRAL, and the stock closed Friday at 4.9 cents. Please begin your research here www.gold-american.com and here http://clicks.aweber.com/y/ct/?l=K15Ol&m=1dtogFKulu_ipC&b=fzcihwSH8729xeeup6Xq0w Here are a few facts to get you started. VRAL discovers and develops drug therapies. VRAL has been researching treatments and testing drug therapies for HIV/AIDS, Lyme Disease, Strep, Staph and drug resistant tumors. VRAL's lead scientist recently discovered a technology that may become new therapies and new vaccines for the deadly HIV virus. Recently, one of VRAL's lead scientists, Dr. M. Karen Newell, Ph.D., obtained nearly $1 million in new funding to support her promising research. The new grants have enabled VRAL, to accelerate the pace of its research, hire additional staff and move closer to its goal of bringing drug compounds to the marketplace. VRAL announced last month that it has granted a renowned London research team the right to investigate its HIV/AIDS drug compound. VRAL is moving in the right direction, and I look forward to seeing how this story develops. Biotech stocks have been particularly successful in the penny stock market, and whenever you can find one with a great story at a low price its worth a strong look. Here are some bio-tech stocks that exploded last year. VERMILLION INC went from 5 cents to $28! That's right, that's not a typo, 28 dollars, not 28 cents. 56,800% price gain!!! VKNG went from .003 to $1.00 in 3 weeks for a 33,233% price gain!! NEPH went from .10 to $2.63 for a 2530% price gain. As you can see there is potential for HUGE price gains for bio-tech stocks on the OTC market. VRAL has a strong story and with the right news it could be the next huge bio-tech winner. Get ready to book your profits with VRAL As always, do your own research, always use stop loss orders to protect yourself, and book your profits when in a position to do so. Good Investing, Mark If you do not trade with a broker that allows stops GET ONE. ChoiceTrades does allow stops and they only charge $5 commissions on OTC stocks. Open an account by following this link. http://clicks.aweber.com/y/ct/?l=K15Ol&m=1dtogFKulu_ipC&b=kE9ycHEiJvQEeC_HYqAVAQ We can now be found on Facebook at http://clicks.aweber.com/y/ct/?l=K15Ol&m=1dtogFKulu_ipC&b=9bRVuAnAJiBobExLUeIkWQ You can also follow us on Twitter at http://clicks.aweber.com/y/ct/?l=K15Ol&m=1dtogFKulu_ipC&b=UR9IN40UdrgpgXD7AIjdMg Important Disclaimer: WFWS Consulting Inc (who along with its affiliates, subsidiaries, officers, directors, representatives and agents is collectively referred to as "WFWS") maintains this website and newsletter as a service to its customers, who have paid for the publication of the information regarding their respective company or business. By using this website, you agree to the following terms of use, which WFWS may unilaterally change at any time. WFWS is not a Registered Investment Advisor or a Broker/Dealer. No Financial Advice or Recommendation Made by WFWS: THIS IS A PAID ADVERTISEMENT USED TO GENERATE EXPOSURE OF THE COMPANY OR COMPANIES MENTIONED IN THE NEWSLETTER. The advertisements and materials relating to WFWS's respective customers are not intended directly or indirectly provide advice as to the advisability of investing in, purchasing, holding or selling such securities. Instead WFWS's customers have prepared and paid for the advertising; and the publications are not endorsements, recommendations, analysis or advisors of any nature by WFWS. WFWS does not endorse any opinions or recommendations regarding the materials advertised, nor does it give tax or financial advice or advocate the purchase or sale of any security or investment. All information provided on the WFWS website pertaining to investing, stocks, securities must be understood as information provided and not financial advice. No Representation as to Content of Advertisement: In preparing this publication, WFWS has relied upon information supplied by its customers, which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, WFWS and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. WFWS is not responsible for any claims made by the companies advertised herein. BY ACCESSING THIS WEBSITE, YOU AGREE THAT THE INFORMATION PROVIDED IS "AS IS" AND WITHOUT WARRANTY, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION CURRENTNESS OR RELIABILITY OF THE CONTENT OF THE ADVERTISEMENTS MAINTAINED ON THIS WEBSITE; AND WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. WFWS shall not be liable for any damage or costs arising out of or in any way connected with your use of the materials or advertisements provided or accessed through this website. No Offer of Securities: None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead WFWS strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. WFWS does not offer such advice or analysis, and WFWS further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. Compensation: WFWS received a fee of twenty thousand dollars cash from a third party (Imperial Consulting Network, Inc.) for this VRAL advertisement. This compensation should be viewed as a potential conflict of interest. Buying and Selling of Shares: WFWS's affiliates, officers, directors and employees may have also bought or may buy the shares discussed in this report and may profit in the event those shares rise in value. WFWS intends to any sell shares in the event the shares rise in value. WFWS may sell its shares for less than target prices given in opinions. WFWS will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. Public Filings: WFWS urges its readers who are considering an investment in a specific company to check the company's filings with the Securities and Exchange Commission ("SEC") on the SEC's Edgar Website located at http://clicks.aweber.com/y/ct/?l=K15Ol&m=1dtogFKulu_ipC&b=6ogwWbg2wSFyJp.GEdJ6LQ. No Liability Relating to External Links: This website contains links to other World Wide Web Internet sites, and WFWS is not responsible for the availability of these outside resources, or their contents. WFWS does not endorse, nor is it responsible for any of the contents, advertising products or other materials. Safe Harbor for Forward-Looking Statements: Information presented on the WFWS website contains "forward looking statements" within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results. 1900 Empire Blvd. #212 Webster, New York 14580 To unsubscribe or change subscriber options visit